Clinical Trial

Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)

Study acronym: BronQ Family
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to examine the long-term impact of having a child with Bronchopulmonary Dysplasia (BPD) on the parents and caregivers from the time of diagnosis through adulthood. The primary focus will be on parents and caregivers of children until the age of 18 (\< 18) years who were diagnosed with BPD as newborns. Data will be collected through an online questionnaire in France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States. It will ask about inclusion and exclusion criteria, background information (caregiver, child, and family situation), the child's medical situation, parental health-related quality of life (HRQoL), health literacy, feelings, support structures, and economic burden of the family.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-14; most recent amendment 2025-11-18.
Status change: Not Yet Recruiting → Recruiting 2025-11-18
Trial Details
NCT Number NCT07134387
Lead Sponsor Global Foundation for the Care of Newborn Infants
Collaborators: European Society for Paediatric Research (ESPR), Union of European Neonatal and Perinatal Societies (UENPS), European Respiratory Society (ERS)
Conditions Bronchopulmonary Dysplasia (BPD), Chronic Lung Disease of Newborn, HRQOL (Health Related Quality Of Life)
Enrollment 480 participants
Start Date 2025-09-16
Primary Completion 2026-02 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-21